UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX® (bimekizumab-bkzx) is now available. These ...

UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available.

UCB Investment Limited has successfully closed the “SJIBL 3rd Mudaraba Subordinated Bond” worth Tk 500 crore, issued by ...

Barclays analyst Charles Pitman CFA maintained a Buy rating on UCB SA (0NZT – Research Report) yesterday and set a price target of €240.00. The ...

UCB Investment Limited has successfully closed the SJIBL 3rd Mudaraba Subordinated Bond of Tk500 crore, issued by Shahjalal ...

Get a deeper insight into the potential performance of United Community Banks (UCB) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the ...

GET MORE AI-GENERATED SIGNALS: January 10, 2025, 13:48 pm ET, BY Joseph H.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

The substantial data supporting platelet-rich plasma (PRP) therapy and exosomes for androgenic alopecia have yet to convince ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...